References
Herrick AL (2005) Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford) 44:587–596
Bakst R, Merola JF, Franks AG Jr, Sanchez M (2008) Raynaud’s phenomenon: pathogenesis and management. J Am Acad Dermatol 59:633–653
Lau CS, McLaren M, Mackay I, Belch JJ (1993) Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud’s phenomenon. Ann Rheum Dis 52:443–448
Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MI (1996) Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud’s phenomenon and systemic sclerosis. Ann Rheum Dis 55:122–127
Brevetti G, De Caterina M, Martone VD, Corrado S, Silvestro A, Spadaro G, Scopacasa F (2000) Measurement of soluble adhesion molecules in primary Raynaud’s phenomenon and in Raynaud’s phenomenon secondary to connective tissue diseases. Int J Clin Lab Res 30:75–81
Marasini B, Casari S, Bestetti A, Maioli C, Cugno M, Zeni S, Turri O, Guagnellini E, Biondi ML (2000) Homocysteine concentration in primary and systemic sclerosis associated Raynaud’s phenomenon. J Rheumatol 27:2621–2623
Fraenkel L, Tofler GH, Zhang Y, Silbershatz H, D’Agostino RB, Wilson PW, Felson DT (2000) The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud’s phenomenon in men and women. Am J Med 108:583–586
Author information
Authors and Affiliations
Corresponding author
Additional information
A. T. Takats and A. H. Shemirani contributed equally to this work.
Rights and permissions
About this article
Cite this article
Takáts, AT., Shemirani, AH., Zsóri, KS. et al. Association of von Willebrand factor and fibrinogen plasma levels with primary Raynaud’s phenomenon in male and female patients. Rheumatol Int 33, 1083–1084 (2013). https://doi.org/10.1007/s00296-011-2236-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2236-9